AR&C provides advisory services into Public Healthcare, HealthTech, MedTech and SaaS.
Advisory Services
HealthTech Advisory
HealthTech is an emerging innovation in healthcare industry. Healthcare providers need to be in alignement with various technology interventions and adaptability. Our advisory works on finding and collaborating with such technologies.
Public Policy Healthcare Advisory
As public healthcare advisers, we work with government institutions, NGO, publishers to identify the gaps in public healthcare policies. Compare other countries systems and advises in align with Government initiatives.
Liaise with WHO, UN, Central Government, State government bodies, inter and intra country alliances.
MedTech Advisory
Advises medtech leaders on complex questions, growing their business and driving enhanced shareholder value where medical technology challenges are ranging from product launches to pricing, sales, contracting and communicating value.
Working with Medical Technology companies to develop solutions across the patient’s entire healthcare journey/lifecycle.
SaaS Advisory
Software as a Service (SaaS) play a crucial role in organisations and government bodies. We advise on best software technologies to work with, in order to reduce the waste and increase human efficiency using design thinking methodology and frameworks.
Case Studies

Digitisation of healthcare infrastructure.
What are the innovations required for incorporating digital frameworks in addition to current processes using design thinking and innovation frameworks .View more

Non Communicable diseases policy
We identified what developed and developing countries are doing to cure non communicable diseases such as cancers, cardiovascular disease, diabetes, metabolic disorders and chronic lung illnesses.View more
Testimonials
Healthcare architecture created by AR&C is an important document for the assessment of our future public policies.
Govt Employee
Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result, the medicines become ineffective and infections persist in the body, increasing the risk of spread to others. AR&C presented a report to WHO for some facts into AMR segment across continents.
WHO
